 | • レポートコード：MRC2Q12-19060 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、フォンダパリヌクスの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフォンダパリヌクスのグローバル市場のxxx％を占める「ブランド医薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「深部静脈血栓症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 フォンダパリヌクスの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフォンダパリヌクス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 フォンダパリヌクスのグローバル主要プレイヤーには、Dr. Reddy's Laboratories、Viatris、Abbott、Lee's Pharmaceutical、GlaxoSmithKline、Aspen Pharmacare、Lupin Pharmaceutical、Alchemia、Apicore、Jiangsu Hengrui Medicine、Kaifeng Pharmaceutical Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フォンダパリヌクス市場は、種類と用途によって区分されます。世界のフォンダパリヌクス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ブランド医薬品、ジェネリック医薬品 【用途別セグメント】 深部静脈血栓症、急性冠症候群、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フォンダパリヌクス製品概要 - 種類別市場（ブランド医薬品、ジェネリック医薬品） - 用途別市場（深部静脈血栓症、急性冠症候群、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフォンダパリヌクス販売量予測2017-2028 - 世界のフォンダパリヌクス売上予測2017-2028 - フォンダパリヌクスの地域別販売量 - フォンダパリヌクスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フォンダパリヌクス販売量 - 主要メーカー別フォンダパリヌクス売上 - 主要メーカー別フォンダパリヌクス価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ブランド医薬品、ジェネリック医薬品） - フォンダパリヌクスの種類別販売量 - フォンダパリヌクスの種類別売上 - フォンダパリヌクスの種類別価格 ・用途別市場規模（深部静脈血栓症、急性冠症候群、その他） - フォンダパリヌクスの用途別販売量 - フォンダパリヌクスの用途別売上 - フォンダパリヌクスの用途別価格 ・北米市場 - 北米のフォンダパリヌクス市場規模（種類別、用途別） - 主要国別のフォンダパリヌクス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフォンダパリヌクス市場規模（種類別、用途別） - 主要国別のフォンダパリヌクス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフォンダパリヌクス市場規模（種類別、用途別） - 主要国別のフォンダパリヌクス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフォンダパリヌクス市場規模（種類別、用途別） - 主要国別のフォンダパリヌクス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフォンダパリヌクス市場規模（種類別、用途別） - 主要国別のフォンダパリヌクス市場規模（トルコ、サウジアラビア） ・企業情報 Dr. Reddy's Laboratories、Viatris、Abbott、Lee's Pharmaceutical、GlaxoSmithKline、Aspen Pharmacare、Lupin Pharmaceutical、Alchemia、Apicore、Jiangsu Hengrui Medicine、Kaifeng Pharmaceutical Group ・産業チェーン及び販売チャネル分析 - フォンダパリヌクスの産業チェーン分析 - フォンダパリヌクスの原材料 - フォンダパリヌクスの生産プロセス - フォンダパリヌクスの販売及びマーケティング - フォンダパリヌクスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フォンダパリヌクスの産業動向 - フォンダパリヌクスのマーケットドライバー - フォンダパリヌクスの課題 - フォンダパリヌクスの阻害要因 ・主な調査結果 |
Fondaparinux is an Anticoagulant Used to Prevent Venous Thromboembolism, Treat Deep Vein Thrombosis and Improve Survival After Myocardial Infarction.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Fondaparinux estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Fondaparinux is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Fondaparinux is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Fondaparinux is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Fondaparinux include Dr. Reddy’s Laboratories, Viatris, Abbott, Lee’s Pharmaceutical, GlaxoSmithKline, Aspen Pharmacare, Lupin Pharmaceutical, Alchemia and Apicore, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Fondaparinux companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Fondaparinux market. Further, it explains the major drivers and regional dynamics of the global Fondaparinux market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Dr. Reddy’s Laboratories
Viatris
Abbott
Lee’s Pharmaceutical
GlaxoSmithKline
Aspen Pharmacare
Lupin Pharmaceutical
Alchemia
Apicore
Jiangsu Hengrui Medicine
Kaifeng Pharmaceutical Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Fondaparinux Segment by Type
Brand Drug
Generic Drug
Fondaparinux Segment by Application
Deep Vein Thrombosis
Acute Coronary Syndrome
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fondaparinux market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Fondaparinux market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Fondaparinux, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fondaparinux, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fondaparinux revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Fondaparinux market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Fondaparinux revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Dr. Reddy’s Laboratories, Viatris, Abbott, Lee’s Pharmaceutical, GlaxoSmithKline, Aspen Pharmacare, Lupin Pharmaceutical, Alchemia and Apicore, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fondaparinux in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fondaparinux companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fondaparinux revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fondaparinux Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Fondaparinux Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Deep Vein Thrombosis
1.3.3 Acute Coronary Syndrome
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fondaparinux Market Perspective (2017-2028)
2.2 Fondaparinux Growth Trends by Region
2.2.1 Fondaparinux Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fondaparinux Historic Market Size by Region (2017-2022)
2.2.3 Fondaparinux Forecasted Market Size by Region (2023-2028)
2.3 Fondaparinux Market Dynamics
2.3.1 Fondaparinux Industry Trends
2.3.2 Fondaparinux Market Drivers
2.3.3 Fondaparinux Market Challenges
2.3.4 Fondaparinux Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fondaparinux Players by Revenue
3.1.1 Global Top Fondaparinux Players by Revenue (2017-2022)
3.1.2 Global Fondaparinux Revenue Market Share by Players (2017-2022)
3.2 Global Fondaparinux Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fondaparinux Revenue
3.4 Global Fondaparinux Market Concentration Ratio
3.4.1 Global Fondaparinux Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fondaparinux Revenue in 2021
3.5 Fondaparinux Key Players Head office and Area Served
3.6 Key Players Fondaparinux Product Solution and Service
3.7 Date of Enter into Fondaparinux Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fondaparinux Breakdown Data by Type
4.1 Global Fondaparinux Historic Market Size by Type (2017-2022)
4.2 Global Fondaparinux Forecasted Market Size by Type (2023-2028)
5 Fondaparinux Breakdown Data by Application
5.1 Global Fondaparinux Historic Market Size by Application (2017-2022)
5.2 Global Fondaparinux Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fondaparinux Market Size (2017-2028)
6.2 North America Fondaparinux Market Size by Type
6.2.1 North America Fondaparinux Market Size by Type (2017-2022)
6.2.2 North America Fondaparinux Market Size by Type (2023-2028)
6.2.3 North America Fondaparinux Market Share by Type (2017-2028)
6.3 North America Fondaparinux Market Size by Application
6.3.1 North America Fondaparinux Market Size by Application (2017-2022)
6.3.2 North America Fondaparinux Market Size by Application (2023-2028)
6.3.3 North America Fondaparinux Market Share by Application (2017-2028)
6.4 North America Fondaparinux Market Size by Country
6.4.1 North America Fondaparinux Market Size by Country (2017-2022)
6.4.2 North America Fondaparinux Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fondaparinux Market Size (2017-2028)
7.2 Europe Fondaparinux Market Size by Type
7.2.1 Europe Fondaparinux Market Size by Type (2017-2022)
7.2.2 Europe Fondaparinux Market Size by Type (2023-2028)
7.2.3 Europe Fondaparinux Market Share by Type (2017-2028)
7.3 Europe Fondaparinux Market Size by Application
7.3.1 Europe Fondaparinux Market Size by Application (2017-2022)
7.3.2 Europe Fondaparinux Market Size by Application (2023-2028)
7.3.3 Europe Fondaparinux Market Share by Application (2017-2028)
7.4 Europe Fondaparinux Market Size by Country
7.4.1 Europe Fondaparinux Market Size by Country (2017-2022)
7.4.2 Europe Fondaparinux Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fondaparinux Market Size (2017-2028)
8.2 Asia-Pacific Fondaparinux Market Size by Type
8.2.1 Asia-Pacific Fondaparinux Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fondaparinux Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fondaparinux Market Share by Type (2017-2028)
8.3 Asia-Pacific Fondaparinux Market Size by Application
8.3.1 Asia-Pacific Fondaparinux Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fondaparinux Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fondaparinux Market Share by Application (2017-2028)
8.4 Asia-Pacific Fondaparinux Market Size by Region
8.4.1 Asia-Pacific Fondaparinux Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fondaparinux Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fondaparinux Market Size (2017-2028)
9.2 Latin America Fondaparinux Market Size by Type
9.2.1 Latin America Fondaparinux Market Size by Type (2017-2022)
9.2.2 Latin America Fondaparinux Market Size by Type (2023-2028)
9.2.3 Latin America Fondaparinux Market Share by Type (2017-2028)
9.3 Latin America Fondaparinux Market Size by Application
9.3.1 Latin America Fondaparinux Market Size by Application (2017-2022)
9.3.2 Latin America Fondaparinux Market Size by Application (2023-2028)
9.3.3 Latin America Fondaparinux Market Share by Application (2017-2028)
9.4 Latin America Fondaparinux Market Size by Country
9.4.1 Latin America Fondaparinux Market Size by Country (2017-2022)
9.4.2 Latin America Fondaparinux Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fondaparinux Market Size (2017-2028)
10.2 Middle East & Africa Fondaparinux Market Size by Type
10.2.1 Middle East & Africa Fondaparinux Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fondaparinux Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fondaparinux Market Share by Type (2017-2028)
10.3 Middle East & Africa Fondaparinux Market Size by Application
10.3.1 Middle East & Africa Fondaparinux Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fondaparinux Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fondaparinux Market Share by Application (2017-2028)
10.4 Middle East & Africa Fondaparinux Market Size by Country
10.4.1 Middle East & Africa Fondaparinux Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fondaparinux Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Dr. Reddy’s Laboratories
11.1.1 Dr. Reddy’s Laboratories Company Details
11.1.2 Dr. Reddy’s Laboratories Business Overview
11.1.3 Dr. Reddy’s Laboratories Fondaparinux Introduction
11.1.4 Dr. Reddy’s Laboratories Revenue in Fondaparinux Business (2017-2022)
11.1.5 Dr. Reddy’s Laboratories Recent Developments
11.2 Viatris
11.2.1 Viatris Company Details
11.2.2 Viatris Business Overview
11.2.3 Viatris Fondaparinux Introduction
11.2.4 Viatris Revenue in Fondaparinux Business (2017-2022)
11.2.5 Viatris Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Fondaparinux Introduction
11.3.4 Abbott Revenue in Fondaparinux Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 Lee’s Pharmaceutical
11.4.1 Lee’s Pharmaceutical Company Details
11.4.2 Lee’s Pharmaceutical Business Overview
11.4.3 Lee’s Pharmaceutical Fondaparinux Introduction
11.4.4 Lee’s Pharmaceutical Revenue in Fondaparinux Business (2017-2022)
11.4.5 Lee’s Pharmaceutical Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Fondaparinux Introduction
11.5.4 GlaxoSmithKline Revenue in Fondaparinux Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Aspen Pharmacare
11.6.1 Aspen Pharmacare Company Details
11.6.2 Aspen Pharmacare Business Overview
11.6.3 Aspen Pharmacare Fondaparinux Introduction
11.6.4 Aspen Pharmacare Revenue in Fondaparinux Business (2017-2022)
11.6.5 Aspen Pharmacare Recent Developments
11.7 Lupin Pharmaceutical
11.7.1 Lupin Pharmaceutical Company Details
11.7.2 Lupin Pharmaceutical Business Overview
11.7.3 Lupin Pharmaceutical Fondaparinux Introduction
11.7.4 Lupin Pharmaceutical Revenue in Fondaparinux Business (2017-2022)
11.7.5 Lupin Pharmaceutical Recent Developments
11.8 Alchemia
11.8.1 Alchemia Company Details
11.8.2 Alchemia Business Overview
11.8.3 Alchemia Fondaparinux Introduction
11.8.4 Alchemia Revenue in Fondaparinux Business (2017-2022)
11.8.5 Alchemia Recent Developments
11.9 Apicore
11.9.1 Apicore Company Details
11.9.2 Apicore Business Overview
11.9.3 Apicore Fondaparinux Introduction
11.9.4 Apicore Revenue in Fondaparinux Business (2017-2022)
11.9.5 Apicore Recent Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Details
11.10.2 Jiangsu Hengrui Medicine Business Overview
11.10.3 Jiangsu Hengrui Medicine Fondaparinux Introduction
11.10.4 Jiangsu Hengrui Medicine Revenue in Fondaparinux Business (2017-2022)
11.10.5 Jiangsu Hengrui Medicine Recent Developments
11.11 Kaifeng Pharmaceutical Group
11.11.1 Kaifeng Pharmaceutical Group Company Details
11.11.2 Kaifeng Pharmaceutical Group Business Overview
11.11.3 Kaifeng Pharmaceutical Group Fondaparinux Introduction
11.11.4 Kaifeng Pharmaceutical Group Revenue in Fondaparinux Business (2017-2022)
11.11.5 Kaifeng Pharmaceutical Group Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Fondaparinux Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Brand Drug
Table 3. Key Players of Generic Drug
Table 4. Global Fondaparinux Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Fondaparinux Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Fondaparinux Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Fondaparinux Market Share by Region (2017-2022)
Table 8. Global Fondaparinux Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Fondaparinux Market Share by Region (2023-2028)
Table 10. Fondaparinux Market Trends
Table 11. Fondaparinux Market Drivers
Table 12. Fondaparinux Market Challenges
Table 13. Fondaparinux Market Restraints
Table 14. Global Fondaparinux Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Fondaparinux Revenue Share by Players (2017-2022)
Table 16. Global Top Fondaparinux by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fondaparinux as of 2021)
Table 17. Ranking of Global Top Fondaparinux Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Fondaparinux Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fondaparinux Product Solution and Service
Table 21. Date of Enter into Fondaparinux Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fondaparinux Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Fondaparinux Revenue Market Share by Type (2017-2022)
Table 25. Global Fondaparinux Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Fondaparinux Revenue Market Share by Type (2023-2028)
Table 27. Global Fondaparinux Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Fondaparinux Revenue Share by Application (2017-2022)
Table 29. Global Fondaparinux Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Fondaparinux Revenue Share by Application (2023-2028)
Table 31. North America Fondaparinux Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Fondaparinux Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Fondaparinux Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Fondaparinux Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Fondaparinux Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Fondaparinux Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Fondaparinux Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Fondaparinux Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Fondaparinux Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Fondaparinux Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Fondaparinux Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Fondaparinux Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Fondaparinux Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Fondaparinux Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Fondaparinux Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Fondaparinux Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Fondaparinux Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Fondaparinux Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Fondaparinux Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Fondaparinux Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Fondaparinux Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Fondaparinux Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Fondaparinux Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Fondaparinux Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Fondaparinux Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Fondaparinux Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Fondaparinux Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Fondaparinux Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Fondaparinux Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Fondaparinux Market Size by Country (2023-2028) & (US$ Million)
Table 61. Dr. Reddy's Laboratories Company Details
Table 62. Dr. Reddy's Laboratories Business Overview
Table 63. Dr. Reddy's Laboratories Fondaparinux Product
Table 64. Dr. Reddy's Laboratories Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 65. Dr. Reddy's Laboratories Recent Developments
Table 66. Viatris Company Details
Table 67. Viatris Business Overview
Table 68. Viatris Fondaparinux Product
Table 69. Viatris Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 70. Viatris Recent Developments
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Fondaparinux Product
Table 74. Abbott Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 75. Abbott Recent Developments
Table 76. Lee's Pharmaceutical Company Details
Table 77. Lee's Pharmaceutical Business Overview
Table 78. Lee's Pharmaceutical Fondaparinux Product
Table 79. Lee's Pharmaceutical Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 80. Lee's Pharmaceutical Recent Developments
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Fondaparinux Product
Table 84. GlaxoSmithKline Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 85. GlaxoSmithKline Recent Developments
Table 86. Aspen Pharmacare Company Details
Table 87. Aspen Pharmacare Business Overview
Table 88. Aspen Pharmacare Fondaparinux Product
Table 89. Aspen Pharmacare Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 90. Aspen Pharmacare Recent Developments
Table 91. Lupin Pharmaceutical Company Details
Table 92. Lupin Pharmaceutical Business Overview
Table 93. Lupin Pharmaceutical Fondaparinux Product
Table 94. Lupin Pharmaceutical Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 95. Lupin Pharmaceutical Recent Developments
Table 96. Alchemia Company Details
Table 97. Alchemia Business Overview
Table 98. Alchemia Fondaparinux Product
Table 99. Alchemia Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 100. Alchemia Recent Developments
Table 101. Apicore Company Details
Table 102. Apicore Business Overview
Table 103. Apicore Fondaparinux Product
Table 104. Apicore Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 105. Apicore Recent Developments
Table 106. Jiangsu Hengrui Medicine Company Details
Table 107. Jiangsu Hengrui Medicine Business Overview
Table 108. Jiangsu Hengrui Medicine Fondaparinux Product
Table 109. Jiangsu Hengrui Medicine Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 110. Jiangsu Hengrui Medicine Recent Developments
Table 111. Kaifeng Pharmaceutical Group Company Details
Table 112. Kaifeng Pharmaceutical Group Business Overview
Table 113. Kaifeng Pharmaceutical Group Fondaparinux Product
Table 114. Kaifeng Pharmaceutical Group Revenue in Fondaparinux Business (2017-2022) & (US$ Million)
Table 115. Kaifeng Pharmaceutical Group Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fondaparinux Market Share by Type: 2021 VS 2028
Figure 2. Brand Drug Features
Figure 3. Generic Drug Features
Figure 4. Global Fondaparinux Market Share by Application: 2021 VS 2028
Figure 5. Deep Vein Thrombosis Case Studies
Figure 6. Acute Coronary Syndrome Case Studies
Figure 7. Others Case Studies
Figure 8. Fondaparinux Report Years Considered
Figure 9. Global Fondaparinux Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Fondaparinux Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Fondaparinux Market Share by Region: 2021 VS 2028
Figure 12. Global Fondaparinux Market Share by Players in 2021
Figure 13. Global Top Fondaparinux Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fondaparinux as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Fondaparinux Revenue in 2021
Figure 15. North America Fondaparinux Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Fondaparinux Market Size Market Share by Type (2017-2028)
Figure 17. North America Fondaparinux Market Size Market Share by Application (2017-2028)
Figure 18. North America Fondaparinux Market Size Share by Country (2017-2028)
Figure 19. United States Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Fondaparinux Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Fondaparinux Market Size Market Share by Type (2017-2028)
Figure 23. Europe Fondaparinux Market Size Market Share by Application (2017-2028)
Figure 24. Europe Fondaparinux Market Size Share by Country (2017-2028)
Figure 25. Germany Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Fondaparinux Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Fondaparinux Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Fondaparinux Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Fondaparinux Market Size Share by Region (2017-2028)
Figure 35. China Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Fondaparinux Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Fondaparinux Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Fondaparinux Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Fondaparinux Market Size Share by Country (2017-2028)
Figure 45. Mexico Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Fondaparinux Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Fondaparinux Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Fondaparinux Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Fondaparinux Market Size Share by Country (2017-2028)
Figure 51. Turkey Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Fondaparinux Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 55. Viatris Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 56. Abbott Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 57. Lee's Pharmaceutical Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 59. Aspen Pharmacare Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 60. Lupin Pharmaceutical Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 61. Alchemia Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 62. Apicore Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 63. Jiangsu Hengrui Medicine Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 64. Kaifeng Pharmaceutical Group Revenue Growth Rate in Fondaparinux Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed